We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Secondary Prevention With Calcium Antagonists After a Myocardial Infarction

Jøgen Fischer Hansen, MD, PhD
Arch Intern Med. 1993;153(19):2277-2281. doi:10.1001/archinte.1993.00410190123015.
Text Size: A A A
Published online


The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 study recently published in the Archives1 demonstrates the importance of testing the value of each calcium-channel blocker for secondary prevention after an acute myocardial infarction and consideration that all calcium-channel blockers are not equal,2 probably contrary to β-blockers.3

In an accompanying editorial, Deedwania and Carbajal4 discuss secondary prevention underlining aspirin and β-blockers as first-time treatment, which is now generally accepted. But, as stated in the editorial, a major problem is that after an acute myocardial infarction only 20% to 30% of the patients were treated with β-blockers. The most likely explanation of this low figure is that contraindications to, or unacceptable side effects of, β-blockers prevent their use in a large number of patients. For this reason, it is important to look for alternatives to β-blockers for secondary prevention.

Deedwania and Carbajal also describe diltiazem as an established


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.